Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
Open Access
- 1 January 2015
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 6 (11) , 1099-1104
Abstract
Background: Unresectable intrahepatic and hilar cholangiocarcinomas carry a dismal prognosis. Systemic chemotherapy and conventional external beam radiation and brachytherapy have been used with limited success. We explored the use of stereotactic body radiotherapy (SBRT) for these patients.Keywords
This publication has 50 references indexed in Scilit:
- Stereotactic body radiotherapy for liver tumorsStrahlentherapie und Onkologie, 2014
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsAnnals of Oncology, 2013
- Liver transplantation for hilar cholangiocarcinomaWorld Journal of Gastroenterology, 2013
- Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct CarcinomaStrahlentherapie und Onkologie, 2010
- Liver transplantation for cholangiocarcinomaTransplant International, 2010
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Clinical Oncology, 2008
- CholangiocarcinomaAnnals of Surgery, 2007
- A Review and Update on CholangiocarcinomaOncology, 2004
- Limitations of conventional doses of chemoradiation for unresectable biliary cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve SurvivalAnnals of Surgery, 1995